NCT03779815
- Conditions
- Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +16 more
- Locations
-
- Ulsan University Hospital Ulsan, South Korea
Clinical trial condition
Hemostatic Disorders
Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.
3,079 public trials
581 recruiting studies
Hemostatic Disorders trial results
Completed
Bortezomib Consolidation Trial
NCT01517724
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University College London London, United Kingdom
NCT01594242
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT00711828
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +35 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic Rochester, Minnesota, United States
NCT01246063
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
NCT01383928
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- UCSF Medical Center Berkeley, California, United States
- City of Hope National Medical Center Duarte, California, United States
- Stanford University Stanford, California, United States
- H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
Completed
Study of Tabalumab (LY2127399) in Japanese Participants With Relapsed or Refactory Multiple Myeloma
NCT01556438
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kyoto, Japan
NCT00807599
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
- Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States
- Memorial Sloan Kettering West Harrison Harrison, New York, United States
- Memorial Sloan Kettering Cancer Center New York, United States
NCT02026505
- Conditions
- Blood Protein Disorders, Cardiotoxins, Cardiovascular Diseases, +16 more
- Locations
-
Not specified
NCT02497378
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Hiroshima, Japan
- Hitachi, Japan
- Nagoya, Japan
- Shibuya City, Japan